StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) stock

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.77−0.06 (-6.87%)

Close on Nov 19, 2026Market cap $9.14MP/E –Yield –

CytoMed Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for CytoMed Therapeutics

CytoMed Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More CytoMed Therapeutics figures

See a number that looks wrong?